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Abstract 
Idiopathic pulmonary hemosiderosis (IPH) is a rare disease
marked by alveolar bleeding and accumulation of hemosiderin in
the lungs. Here we present three cases of IPH. The first case is of
26-year-old male with anemia, hemoptysis and dyspnea.
Bronchoscopy confirmed diffuse alveolar hemorrhage (DAH). A
diagnosis of IPH was made after ruling out other causes of DAH
and observing good response to steroids. The patient’s condition
improved with prednisolone and azathioprine. The second case is
of 26-year-old female with severe anemia. Imaging suggested IPH
and lung biopsy confirmed it. She died shortly afterwards. The
third case is of a 7-year-old male with chronic anemia. CT was
suggestive of IPH and lung biopsy confirmed the diagnosis. Later,
patient developed posterior reversible encephalopathy syndrome
(PRES). This patient is stable on azathioprine and prednisolone.
We aim to emphasize the importance of considering IPH as a dif-
ferential in patients with DAH or chronic anemia.
Introduction
Idiopathic pulmonary hemosiderosis (IPH) is a life-threaten-
ing parenchymal lung disease characterized by the destruction of
pulmonary microvasculature, leakage of blood into the alveolar
space and accumulation of hemosiderin in the lungs. It classically
presents as a triad of hemoptysis, iron deficiency anemia and alve-
olar infiltrates. The condition is more commonly found in children
with an approximate incidence of 0.24–1.23 cases per million in
different populations [1]. Only 20% of IPH cases occur in adult-
hood [2]. The rarity of the condition and the varying clinical
course has made it difficult to diagnose this disease [3]. 
Here we present three cases of IPH presenting to our center,
including two adult and one pediatric case. Through our report we
aim to emphasize the importance of considering IPH as an impor-
tant differential diagnosis when approaching a patient with diffuse
alveolar hemorrhage or chronic anemia even in adults, given the
potential morbidity and mortality of the disease.
Case #1
A 26-year-old male admitted with complains of generalized
weakness, hemoptysis and dyspnea was found to have a hemoglo-
bin of 5.2g/dl. Gastrointestinal endoscopy was performed to inves-
tigate the cause of anemia but revealed no bleeding source. The
patient had been transfused 5 packs of blood. The patient was
tachypneic (respiratory rate: 30/min) and oxygen saturation of 75%
on room air with bilateral crackles on chest auscultation Chest x-ray
revealed bilateral alveolar infiltrates. High Resolution Computed
Tomography (HRCT) chest delineated diffuse bilateral alveolar
infiltrates (Figure 1). Bronchoscopy was done which showed blood
throughout the airways and sequential bronchoalveolar lavage con-
firmed diffuse alveolar hemorrhage (DAH). Bronchoalveolar
lavage (BAL) was negative for any microbiological organism or
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malignant cells. Lung biopsy was not done because of hypoxia. The
patient had negative antinuclear antibody (ANA), antidouble strand-
ed DNA (anti-dsDNA), Human Immunodeficiency Virus (HIV) and
antineutrophilic cytoplasmic antibody (ANCA) tests. Sputum acid-
fast bacilli (AFB) smear, acid-fast bacilli (AFB) culture and
GeneXpert MTB/RIF (diagnostic test that can identify
Mycobacterium tuberculosis (MTB) DNA and resistance to
rifampicin (RIF)) were negative for Mycobacterium tuberculosis.
The patient was started on intravenous methylprednisolone, on
which his condition improved. Considering his history and ruling
out autoimmune and infectious etiologies and vasculitis, a diagnosis
of IPH was made after exclusion of other causes of DAH and seeing
the good response to steroid therapy. The patient’s treatment regimen
was later switched to 1 mg/kg oral prednisolone and 200 mg ferrous
sulfate. After discharge, the patient had a relapse of symptoms on a
tapering dose of steroids and his hemoglobin level dropped back to
6.9 mg/dl. Hence, the patient was restarted on prednisolone with
addition of azathioprine. The patient responded well to this treat-
ment. Within 6 weeks his symptoms resolved and his chest x-ray
returned to normal.
Case #2
A 26-year-old female presented with four years long history of
cough along with scanty hemoptysis on and off. Her cough and
dyspnea had worsened in the 3 months prior to presentation. She
also gave history of recurrent anemia and multiple blood transfu-
sions. On examination, her oxygen saturation was 86% on room air
and she had bilateral fine crackles more marked at lower parts of
chest. Her hemoglobin at presentation was 8.0 g/dl. Her Chest X-
ray and CT scan findings were suggestive of interstitial lung dis-
ease. She was transfused two units of packed cells and an open
lung biopsy was done. Biopsy findings were consistent with IPH.
This patient was started on steroids but she did not respond. She
died few weeks later with respiratory failure secondary to hospital
acquired pneumonia.
Case #3
A 7-year-old boy who had experienced shortness of breath and
anemia for the past five years, presented for evaluation of chronic
anemia. The patient had been transfused blood twice in the years
before presenting to us. 
At presentation, he had a hemoglobin level of 3.2 gm/dl. The
patient was transfused one packed cell unit of blood and thereafter
bone trephine revealed absent storage iron on bone marrow, con-
sistent with iron deficiency anemia. The child was then discharged
on ferrous sulfate. After discharge, the patient had frequent hospi-
tal admissions due to cough and fever episodes. Then the patient
was admitted again due to a five-day history of cough, fever res-
piratory distress and decreased oral intake. The patient was intu-
bated and investigations revealed right sided pneumothorax for
which chest tube was inserted. CT scan depicted evidence of dif-
fuse ground glass haze in bilateral lung fields, which led to suspi-
cion of pulmonary hemosiderosis and a subsequent lung biopsy
confirmed the diagnosis (Figure 2 A,B). The patient was started
on prednisolone 10 mg twice daily. The child was later hospital-
ized after he presented with multiple episodes of tonic clonic
seizures. CT scan brain showed bilateral infarcts following a
venous territory. Glascow Coma Scale score improved with time
(8/15 at presentation to 15/15). However, the weakness on the
right side persisted in both the upper and lower limbs. Magnetic
resonance venography (MRV) was negative for any thrombus,
whereas magnetic resonance imaging (MRI) brain showed multi-
ple high signals in the cortex and white matter primarily in bilat-
eral parieto-occipital and few areas in bilateral frontal lobes lead-
ing to a diagnosis of posterior reversible encephalopathy syn-
drome (PRES), possibly due to hypertension. ECHO and Doppler
renal ultrasound, 24 h vanillylmandelic acid (VMA) and renin
was normal. The patient was prescribed amlodipine, atenolol, aza-
thioprine 37.5 mg once daily, prednisolone 20 mg twice daily and
valproate sodium 400 mg twice daily. The patient remains stable
on the afore mentioned drugs ten years after his initial presenta-
tion to our center. 
Discussion
Many different hypotheses have been postulated in an
attempt to explain the etiology of IPH including allergic, envi-
ronmental, auto immune and genetic causes. The allergic hypoth-
esis arises from the frequent association between cow’s milk
allergy and IPH (Heiner syndrome) [4]. The environmental theo-
ry emerged after the development of IPH in children after expo-
sure to Stachybotris chartarum [5]. IPH has been reported in sib-
lings leading to the notion of an underlying genetic etiology.
However, IPH has not been ascribed to a specific gene [6]. The
auto-immune theory is corroborated by the frequent association
of IPH with many different autoimmune diseases like
immunoglobulin gammopathies, celiac disease, rheumatoid
arthritis and glomerulonephritis [7]. Several studies have delin-
eated that 1 in 4 children who survive IPH go on to develop auto
immune diseases [8]. The positive influence of immunosuppres-
sants in treatment of IPH further endorses the immunological the-
ory. IPH accompanied by celiac disease is referred to as Lane-
Hamilton syndrome. A gluten free diet has been reported to cause
a dramatic amelioration in not only the symptoms of celiac dis-
ease but also those of IPH [9]. The French RespiRare cohort
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Figure 1. High resolution computed tomography (HRCT) scan
chest of Patient 1 showing diffuse bilateral alveolar infiltrates.
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study further bolstered the notion of an autoimmune basis for
IPH based on the findings that 68% of IPH patients had auto-
immune antibodies at presentation, the most common being anti
smooth muscle antibodies (50%) and anti-nuclear antibodies
(45%). Moreover, celiac disease anti-bodies (anti-gliadin, anti-
endomysium and anti-transglutaminase antibodies) were present
in 28% of patients. A surprising finding in the aforementioned
study was the high prevalence (20%) of Down syndrome in IPH
patients whereas the incidence of Down syndrome in the French
population is only 1/2000 births annually. Down syndrome is
also associated with a worse prognosis for IPH [10].
Patients who suffer from IPH generally show clinical find-
ings of recurrent cough, shortness of breath and hemoptysis.
Further investigations reveal the presence of iron deficiency ane-
mia and pulmonary infiltrates attributed to alveolar capillary
bleeding and elevated levels of hemosiderin in the lungs. The
clinical course can vary from patient to patient, especially in chil-
dren. A systematic review demonstrated that in adults the most
common presentations were hemoptysis, dyspnea and anemia
(81%, 62% and 54%, respectively). In contrast, in children ane-
mia may be the first and only finding, with hemoptysis being
much less commonly encountered [11]. According to a study car-
ried out in Romania, among the fifteen children diagnosed with
IPH from 1984 to 2006, only 4 presented with the classical triad
of IPH [11]. A cohort of 25 pediatric IPH cases delineated the
most common presentations to be anemia and dyspnea (64% and
68%, respectively) with hemoptysis only reported in 50% of
cases [12]. Amongst the patients described in our series as well,
adults manifested the classical triad of IPH whereas the pediatric
patient’s first and main complaint was anemia, followed by dys-
pnea. A worrying factor is the delay in diagnosis of IPH which
was seen in all our cases and has also been noted in various pre-
vious studies and ranges from 1-6.3 years [13]. The development
of posterior reversible encephalopathy syndrome (PRES) in Case
#3 is a unique feature, with no associations between PRES and
IPH reported other than in this patient. 
Chest X-ray and computed tomography (CT) usually reveal
nonspecific findings, making bronchoalveolar lavage (BAL) sig-
nificant for the primary diagnosis of diffuse alveolar hemorrhage
(DAH). During acute DAH, diffuse lung infiltrates are exhibited
on CT chest and pulmonary function tests (PFTs) show increased
diffusion capacity for carbon monoxide, which is strongly sugges-
tive of alveolar hemorrhage. A diagnosis of IPH can only be final-
ized after excluding all other possible causes of DAH because IPH
does not have pathognomonic findings. Generally, bland alveolar
hemorrhage with no evidence of vasculitis and/or accumulation of
immune complexes within lung parenchyma is exhibited.
Siderophages in gastric juice content has also been reported to aid
diagnosis in a few cases reported in literature. Lung biopsy, how-
ever, is the gold standard tool to diagnose IPH [13]. 
Due to the absence of fundamental diagnostic criteria, thera-
peutic decisions made against IPH are based on earlier case reports
and case studies which favor the corticosteroids use [1,3,10,14].
Corticosteroids have shown to reduce the risk of pulmonary fibro-
sis and relapses of alveolar hemorrhage in patients with IPH, in
addition to increasing survival. Immunosuppressive agents, mainly
azathioprine, hydroxychloroquine and cyclophosphamide, have
shown benefit in patients with unfavorable response to corticos-
teroids. Azathioprine in combination with corticosteroids has
proven to be effective in reducing the risk of relapse [2]. Two cases
of lung transplantation in IPH patients have been described in lit-
erature, however, IPH recurrence in transplanted lungs precluded
any further attempts at transplantation [15].
IPH is characterized by a highly variable prognosis, with acute
exacerbations afflicting most patients. A study has demonstrated a
5-year survival rate of 86% as a ramification of aggressive
immunosuppressive therapy. Previous studies had shown mean
survival time ranging from 2.5-5 years after diagnosis. Previous
studies point towards a better prognosis for adult patients com-
pared to pediatric patients. A systematic review of all adult cases
over 15 years delineated mortality in acute stage to be 14%. Other
studies have also shown the mortality from IPH to range between
14-29% and occurring commonly due to acute or chronic respira-
tory failure, despite immunosuppressive therapy [16]. In our series,
one of our three patients died due to acute respiratory failure while
being admitted for treatment of IPH.
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Figure 2. Lung biopsy findings of Patient 3. Haemosiderin laden macrophages in the alveoli (A), highlighted by Perl’s Prussian Blue
stain for iron (B).
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Conclusions
Given the severity of the illness, it is imperative for clinicians
to consider IPH as an important differential in adult patients who
present with diffuse alveolar hemorrhage and also in children with
long standing anemia who do not respond to iron therapy. There
needs to be a greater awareness amongst physicians regarding IPH
so that it can be correctly diagnosed and thus successfully treated.
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